Proteomic profiling of a mouse model for ovarian Granulosa cell tumor identifies VCP as a highly sensitive serum tumor marker in several human cancers

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Laguë, Marie Noëlle ^a   Romieu Mourez, Raphaëlle ^b   Bonneil, Éric ^c   Boyer, Alexandre ^a   Pouletty, Nicolas ^a   Mes Masson, Anne Marie ^d   Thibault, Pierre ^c   Nadeau, Marie Ève ^a   Boerboom, Derek ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c Institut du Cancer de Montreal   (Canada)

^d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ENOLASE; ENOLASE 1; HEAT SHOCK PROTEIN; INHIBIN A; INHIBIN B; TUMOR MARKER; UNCLASSIFIED DRUG; VALOSIN CONTAINING PROTEIN; VINCULIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL; CANCER PATIENT; COLON CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; GRANULOSA CELL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; LUNG CANCER; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; MOUSE; NONHODGKIN LYMPHOMA; NONHUMAN; OVARY CARCINOMA; PANCREAS CANCER; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEOMICS; SENSITIVITY AND SPECIFICITY;

ADENOSINE TRIPHOSPHATASES; ANIMALS; BETA CATENIN; CELL CYCLE PROTEINS; FEMALE; GRANULOSA CELL TUMOR; HUMANS; MICE; MICE, TRANSGENIC; OVARIAN NEOPLASMS; PROTEOME; PTEN PHOSPHOHYDROLASE; TUMOR MARKERS, BIOLOGICAL;

MUS MUSCULUS;

EID: 84864741041     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042470     Document Type: Article

References (26)

1. Perkins GL, Slater ED, Sanders GK, Prichard JG, (2003) Serum tumor markers. Am Fam Physician 68: 1075-1082.
2. Alaiya A, Al-Mohanna M, Linder S, (2005) Clinical cancer proteomics: promises and pitfalls. J Proteome Res 4: 1213-1222.
3. Wei BR, Hoover SB, Ross MM, Zhou W, Meani F, et al. (2009) Serum S100A6 concentration predicts peritoneal tumor burden in mice with epithelial ovarian cancer and is associated with advanced stage in patients. PLoS One 4: e7670.
4. Pitteri SJ, JeBailey L, Faca VM, Thorpe JD, Silva MA, et al. (2009) Integrated proteomic analysis of human cancer cells and plasma from tumor bearing mice for ovarian cancer biomarker discovery. PLoS One 4: e7916.
5. Mullany LK, Fan HY, Liu Z, White LD, Marshall A, et al. (2011) Molecular and functional characteristics of ovarian surface epithelial cells transformed by KrasG12D and loss of Pten in a mouse model in vivo. Oncogene 30: 3522-3536.
6. Boerboom D, Paquet M, Hsieh M, Liu J, Jamin SP, et al. (2005) Misregulated Wnt/beta-catenin signaling leads to ovarian granulosa cell tumor development. Cancer Res 65: 9206-9215.
7. Lague MN, Paquet M, Fan HY, Kaartinen MJ, Chu S, et al. (2008) Synergistic effects of Pten loss and WNT/CTNNB1 signaling pathway activation in ovarian granulosa cell tumor development and progression. Carcinogenesis 29: 2062-2072.
8. Geerts I, Vergote I, Neven P, Billen J, (2009) The role of inhibins B and antimullerian hormone for diagnosis and follow-up of granulosa cell tumors. Int J Gynecol Cancer 19: 847-855.
9. Carlson KJ, Skates SJ, Singer DE, (1994) Screening for ovarian cancer. Ann Intern Med 121: 124-132.
10. Sturgeon CM, Duffy MJ, Stenman UH, Lilja H, Brunner N, et al. (2008) National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers. Clin Chem 54: e11-79.
11. Halawani D, Latterich M, (2006) p97: The cell's molecular purgatory? Mol Cell 22: 713-717.
12. Weihl CC, (2011) Another VCP interactor: NF is enough. J Clin Invest 121: 4627-4630.
13. Watts GD, Wymer J, Kovach MJ, Mehta SG, Mumm S, et al. (2004) Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 36: 377-381.
14. Dai RM, Chen E, Longo DL, Gorbea CM, Li CC, (1998) Involvement of valosin-containing protein, an ATPase Co-purified with IkappaBalpha and 26 S proteasome, in ubiquitin-proteasome-mediated degradation of IkappaBalpha. J Biol Chem 273: 3562-3573.
15. Alexandru G, Graumann J, Smith GT, Kolawa NJ, Fang R, et al. (2008) UBXD7 binds multiple ubiquitin ligases and implicates p97 in HIF1alpha turnover. Cell 134: 804-816.
16. Valle CW, Min T, Bodas M, Mazur S, Begum S, et al. (2011) Critical role of VCP/p97 in the pathogenesis and progression of non-small cell lung carcinoma. PLoS One 6: e29073.
17. Fry WH, Simion C, Sweeney C, Carraway KL 3rd, (2011) Quantity control of the ErbB3 receptor tyrosine kinase at the endoplasmic reticulum. Mol Cell Biol 31: 3009-3018.
18. Tsujimoto Y, Tomita Y, Hoshida Y, Kono T, Oka T, et al. (2004) Elevated expression of valosin-containing protein (p97) is associated with poor prognosis of prostate cancer. Clin Cancer Res 10: 3007-3012.
19. Yamamoto S, Tomita Y, Hoshida Y, Iizuka N, Kidogami S, et al. (2004) Expression level of valosin-containing protein (p97) is associated with prognosis of esophageal carcinoma. Clin Cancer Res 10: 5558-5565.
20. Yamamoto S, Tomita Y, Hoshida Y, Iizuka N, Monden M, et al. (2004) Expression level of valosin-containing protein (p97) is correlated with progression and prognosis of non-small-cell lung carcinoma. Ann Surg Oncol 11: 697-704.
21. Yamamoto S, Tomita Y, Hoshida Y, Nagano H, Dono K, et al. (2004) Increased expression of valosin-containing protein (p97) is associated with lymph node metastasis and prognosis of pancreatic ductal adenocarcinoma. Ann Surg Oncol 11: 165-172.
22. Yamamoto S, Tomita Y, Nakamori S, Hoshida Y, Iizuka N, et al. (2004) Valosin-containing protein (p97) and Ki-67 expression is a useful marker in detecting malignant behavior of pancreatic endocrine neoplasms. Oncology 66: 468-475.
23. Yamamoto S, Tomita Y, Nakamori S, Hoshida Y, Nagano H, et al. (2003) Elevated expression of valosin-containing protein (p97) in hepatocellular carcinoma is correlated with increased incidence of tumor recurrence. J Clin Oncol 21: 447-452.
24. Yamamoto S, Tomita Y, Uruno T, Hoshida Y, Qiu Y, et al. (2005) Increased expression of valosin-containing protein (p97) is correlated with disease recurrence in follicular thyroid cancer. Ann Surg Oncol 12: 925-934.
25. Yamamoto S, Tomita Y, Hoshida Y, Sakon M, Kameyama M, et al. (2004) Expression of valosin-containing protein in colorectal carcinomas as a predictor for disease recurrence and prognosis. Clin Cancer Res 10: 651-657.
26. Zeleznik AJ, Midgley AR Jr, Reichert LE Jr, (1974) Granulosa cell maturation in the rat: increased binding of human chorionic gonadotropin following treatment with follicle-stimulating hormone in vivo. Endocrinology 95: 818-825.